• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola.安哥拉罗安达的 SARS-CoV-2 感染的社会人口学特征和危险因素。
PLoS One. 2021 Mar 25;16(3):e0249249. doi: 10.1371/journal.pone.0249249. eCollection 2021.
2
Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola.安哥拉罗安达的 SARS-CoV-2 与虫媒传染病的合并感染。
J Med Virol. 2022 Jan;94(1):366-371. doi: 10.1002/jmv.27354. Epub 2021 Sep 27.
3
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola.安哥拉罗安达健康献血者中抗 SARS-CoV-2 抗体的血清流行率和危险因素。
BMC Infect Dis. 2021 Nov 2;21(1):1131. doi: 10.1186/s12879-021-06814-0.
4
Clinical characteristics and variables associated with COVID-19 morbidity and mortality in Luanda, Angola, in the first year of the pandemic.安哥拉罗安达市在大流行第一年与 COVID-19 发病率和死亡率相关的临床特征和变量。
Afr Health Sci. 2023 Dec;23(4):51-63. doi: 10.4314/ahs.v23i4.9.
5
Prevalence and Risk Factors of SARS-CoV-2 Infection among Parturients and Newborns from Luanda, Angola.安哥拉罗安达产妇和新生儿中新冠病毒感染的患病率及危险因素
Pathogens. 2021 Nov 16;10(11):1494. doi: 10.3390/pathogens10111494.
6
COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.检测时的 COVID-19 症状与 SARS-CoV-2 检测门诊患者的阳性率之间的关系。
PLoS One. 2021 Dec 10;16(12):e0260879. doi: 10.1371/journal.pone.0260879. eCollection 2021.
7
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.牛津皇家全科医生学院研究和监测中心初级保健网络中 SARS-CoV-2 患者的风险因素:一项横断面研究。
Lancet Infect Dis. 2020 Sep;20(9):1034-1042. doi: 10.1016/S1473-3099(20)30371-6. Epub 2020 May 15.
8
Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak?马来西亚私人中心寻求 COVID-19 检测患者的临床和流行病学特征:私营医疗保健在抗击疫情方面是否发挥作用?
PLoS One. 2021 Oct 14;16(10):e0258671. doi: 10.1371/journal.pone.0258671. eCollection 2021.
9
Covid-19 presentation among symptomatic healthcare workers in Ireland.爱尔兰有症状的医护人员中的新冠病毒(Covid-19)表现。
Occup Med (Lond). 2021 Apr 9;71(2):95-98. doi: 10.1093/occmed/kqab012.
10
Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.安大略省多伦多市接受门诊检测人群中新发嗅觉丧失与 SARS-CoV-2 检测阳性之间的关联:一项回顾性横断面研究。
CMAJ Open. 2021 Dec 7;9(4):E1134-E1140. doi: 10.9778/cmajo.20210085. Print 2021 Oct-Dec.

引用本文的文献

1
Seroprevalence and Risk Factors of STIs among Rejected Blood Donors at the National Blood Transfusion Service in Angola.安哥拉国家输血服务中心被拒献血者中性传播感染的血清流行率及危险因素
AIDS Behav. 2025 Apr 5. doi: 10.1007/s10461-025-04700-3.
2
Insights into SARS-CoV-2 in Angola during the COVID-19 peak: Molecular epidemiology and genome surveillance.安哥拉 COVID-19 高峰期间对 SARS-CoV-2 的了解:分子流行病学和基因组监测。
Influenza Other Respir Viruses. 2023 Sep 22;17(9):e13198. doi: 10.1111/irv.13198. eCollection 2023 Sep.
3
Blood pressure pattern among blood donors exposed to SARS-CoV-2 in Luanda, Angola: A retrospective study.安哥拉罗安达接触新型冠状病毒的献血者的血压模式:一项回顾性研究。
Health Sci Rep. 2023 Aug 16;6(8):e1498. doi: 10.1002/hsr2.1498. eCollection 2023 Aug.
4
Risk factors for SARS-CoV-2 infection during the early stages of the COVID-19 pandemic: a systematic literature review.COVID-19 大流行早期 SARS-CoV-2 感染的风险因素:系统文献回顾。
Front Public Health. 2023 Jul 31;11:1178167. doi: 10.3389/fpubh.2023.1178167. eCollection 2023.
5
Immune profile of healthcare professionals six months after vaccination or exposure to SARS-CoV-2 in Angola.安哥拉医护人员在接种疫苗或接触新冠病毒六个月后的免疫情况
Health Sci Rep. 2023 Jan 11;6(1):e1058. doi: 10.1002/hsr2.1058. eCollection 2023 Jan.
6
Clinical Features Related to Severity and Mortality among COVID-19 Patients in a Pre-Vaccine Period in Luanda, Angola.安哥拉罗安达疫苗接种前时期COVID-19患者中与严重程度和死亡率相关的临床特征
Trop Med Infect Dis. 2022 Oct 29;7(11):338. doi: 10.3390/tropicalmed7110338.
7
What have we learned about socioeconomic inequalities in the spread of COVID-19? A systematic review.关于新冠病毒传播中的社会经济不平等,我们了解到了什么?一项系统综述。
Sustain Cities Soc. 2022 Nov;86:104158. doi: 10.1016/j.scs.2022.104158. Epub 2022 Aug 31.
8
Early Evidence of Circulating SARS-CoV-2 in Unvaccinated and Vaccinated Measles Patients, September 2019-February 2020.2019年9月至2020年2月未接种疫苗和接种疫苗的麻疹患者中循环SARS-CoV-2的早期证据。
Infect Drug Resist. 2022 Feb 19;15:533-544. doi: 10.2147/IDR.S344437. eCollection 2022.
9
Prevalence and Risk Factors of SARS-CoV-2 Infection among Parturients and Newborns from Luanda, Angola.安哥拉罗安达产妇和新生儿中新冠病毒感染的患病率及危险因素
Pathogens. 2021 Nov 16;10(11):1494. doi: 10.3390/pathogens10111494.
10
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola.安哥拉罗安达健康献血者中抗 SARS-CoV-2 抗体的血清流行率和危险因素。
BMC Infect Dis. 2021 Nov 2;21(1):1131. doi: 10.1186/s12879-021-06814-0.

本文引用的文献

1
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.PROTECT 试验:羟氯喹对比观察支持用于预防或 COVID-19 早期治疗的一项集群随机对照研究:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jul 31;21(1):689. doi: 10.1186/s13063-020-04527-4.
2
Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.巴西里约热内卢献血者中抗 SARS-CoV-2 的血清流行率。
Rev Saude Publica. 2020;54:69. doi: 10.11606/s1518-8787.2020054002643. Epub 2020 Jul 6.
3
COVID-19 in Africa: care and protection for frontline healthcare workers.非洲的 COVID-19:为一线医护人员提供护理和保护。
Global Health. 2020 May 15;16(1):46. doi: 10.1186/s12992-020-00574-3.
4
Epidemiology of COVID-19.新型冠状病毒肺炎流行病学。
Turk J Med Sci. 2020 Apr 21;50(SI-1):563-570. doi: 10.3906/sag-2004-172.
5
COVID-19 and Older Adults: What We Know.COVID-19 与老年人:我们已知的情况。
J Am Geriatr Soc. 2020 May;68(5):926-929. doi: 10.1111/jgs.16472. Epub 2020 Apr 20.
6
Clinical observation and management of COVID-19 patients.新型冠状病毒肺炎患者的临床观察与管理。
Emerg Microbes Infect. 2020 Dec;9(1):687-690. doi: 10.1080/22221751.2020.1741327.
7
Clinical course and mortality risk of severe COVID-19.重症新型冠状病毒肺炎的临床病程及死亡风险
Lancet. 2020 Mar 28;395(10229):1014-1015. doi: 10.1016/S0140-6736(20)30633-4. Epub 2020 Mar 17.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.

安哥拉罗安达的 SARS-CoV-2 感染的社会人口学特征和危险因素。

Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola.

机构信息

Centro de Investigação em Saúde de Angola, Caxito, Angola.

Instituto Nacional de Investigação em Saúde, Luanda, Angola.

出版信息

PLoS One. 2021 Mar 25;16(3):e0249249. doi: 10.1371/journal.pone.0249249. eCollection 2021.

DOI:10.1371/journal.pone.0249249
PMID:33765102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7993870/
Abstract

This study aimed to investigate the characteristics related to SARS-CoV-2 in Luanda, Angola. A total of 622 individuals were screened for SARS-CoV-2 from January to September 2020. Chi-square and logistic regression were used to identify the relationship between sociodemographic characteristics and SARS-CoV-2. Of the 622 tested, 14.3% tested positive. The infection rate was the same for both genders (14.3%). Individuals ≥40 years old, from non-urbanized areas, and healthcare professionals had a higher frequency of infection. The risk of infection was very high in individuals ≥60 years old (AOR: 23.3, 95% CI: 4.83-112), in women (AOR: 1.24, 95% CI: 0.76-2.04), in Luanda (AOR: 7.40, 95% CI: 1.64-33.4), and healthcare professionals (AOR: 1.27, 95% CI: 0.60-2.71), whereas a low risk was observed in individuals from urbanized areas (AOR: 0.44, 95% CI: 0.26-0.75). Our results suggest that Angolan authorities should implement a greater effort in non-urbanized areas and among healthcare professionals since when these individuals presented any indication for a COVID-19 test, such as fever/cough/myalgia, they were more likely to test positive for SARS-CoV-2 than having some other cause for symptoms.

摘要

本研究旨在调查安哥拉罗安达与 SARS-CoV-2 相关的特征。2020 年 1 月至 9 月,共对 622 人进行了 SARS-CoV-2 筛查。采用卡方检验和逻辑回归来确定社会人口学特征与 SARS-CoV-2 之间的关系。在 622 名检测者中,14.3%检测呈阳性。男女感染率相同(14.3%)。年龄≥40 岁、来自非城市化地区和医疗保健专业人员感染率更高。≥60 岁(AOR:23.3,95%CI:4.83-112)、女性(AOR:1.24,95%CI:0.76-2.04)、罗安达(AOR:7.40,95%CI:1.64-33.4)和医疗保健专业人员(AOR:1.27,95%CI:0.60-2.71)的感染风险非常高,而来自城市化地区(AOR:0.44,95%CI:0.26-0.75)的感染风险较低。我们的研究结果表明,安哥拉当局应在非城市化地区和医疗保健专业人员中加大努力,因为当这些人出现 COVID-19 检测指征,如发热/咳嗽/肌痛时,他们比因其他原因出现症状更有可能检测出 SARS-CoV-2 呈阳性。